The goal of the recent study with the male enhancement drug “X-Excite” was to establish a suitable tablet size, color, good taste, and suitable tablet hardness. All but the hardness ended up being satisfactory and now several more samples with different pharmaceutical expedients to bring the hardness down to the acceptable range are in process. This process could take another 1 to 2 months before it is complete.
The male sexual enhancement drug, X-Excite, is a new formulation of an existing sexual enhancement drug, which is designed to quickly enter the blood system, maximizing its effectiveness and performance.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
About Global Health Ventures, Inc.
Global Health Ventures, Inc. is a specialty pharma with focus on the Over-The-Counter drug market. The Company has a new proprietary platform technology that delivers many approved drugs via the sublingual (under the tongue) route. This unique method delivers low dose drugs directly to the blood stream, bypassing all the side effects of digestive and liver system breakdowns, while maintaining product efficacy. The Company currently has five products in various stage of development.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
